Home - Medical & Healthcare - Biologics and Biosimilars Market

Global Biologics and Biosimilars Market Analysis, Trends and Forecast 2018-2023

Post on : 2018-06-27

The " Global Biologics and Biosimilars Market Analysis, Trends and Forecast 2018-2023" has been added by Logic Research and Solutions.

“The global Biologics and Biosimilars market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. A report published on 05-June-2018 for US $2980.00 at logicresearch.net”

Biologics and Biosimilars Market

Biologics and Biosimilars Market

The global Biologics and Biosimilars market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Biologics and Biosimilars by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original innovator products, and can be manufactured when the original product's patent expires.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Antibody
Hormone
Growth Factors
Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Content
1 Industry Overview
1.1 Biologics and Biosimilars Industry
1.1.1 Overview
1.1.2 Development of Biologics and Biosimilars
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Biologics and Biosimilars Market by Type
3.1 By Type
3.1.1 Antibody
3.1.2 Hormone
3.1.3 Growth Factors
3.1.4 Others
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.1 Roche (Company Profile, Sales Data etc.)
4.2 Amgen (Company Profile, Sales Data etc.)
4.3 AbbVie (Company Profile, Sales Data etc.)
4.4 Sanofi-Aventis (Company Profile, Sales Data etc.)
4.5 Johnson & Johnson (Company Profile, Sales Data etc.)
4.6 Pfizer (Company Profile, Sales Data etc.)
4.7 Novo Nordisk (Company Profile, Sales Data etc.)
4.8 Eli Lilly (Company Profile, Sales Data etc.)
4.9 Novartis (Company Profile, Sales Data etc.)
4.10 Merck (Company Profile, Sales Data etc.)
4.11 3sbio (Company Profile, Sales Data etc.)
4.12 Changchun High Tech (Company Profile, Sales Data etc.)
4.13 CP Guojian (Company Profile, Sales Data etc.)
4.14 Biotech (Company Profile, Sales Data etc.)
4.15 Gelgen (Company Profile, Sales Data etc.)
4.16 Innovent (Company Profile, Sales Data etc.)
4.17 Dong Bao (Company Profile, Sales Data etc.)
4.18 Ganlee (Company Profile, Sales Data etc.)
4.19 United Laboratories (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Market Demand
6.1 Demand Situation
6.1.1 Demand in Tumor
6.1.2 Demand in Diabetes
6.1.3 Demand in Cardiovascular
6.1.4 Demand in Hemophilia
6.1.5 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion

Table Upstream Segment of Biologics and Biosimilars
Table Application Segment of Biologics and Biosimilars
Table Global Biologics and Biosimilars Market 2012-2023, by Application, in USD Million
Table Major Company List of Antibody
Table Major Company List of Hormone
Table Major Company List of Growth Factors
Table Major Company List of Others
Table Global Biologics and Biosimilars Market 2012-2017, by Type, in USD Million
Table Global Biologics and Biosimilars Market Forecast 2017-2023, by Type, in USD Million
Table Roche Overview List
Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Cost, Gross Margin)
Table Amgen Overview List
Table Biologics and Biosimilars Business Operation of Amgen (Sales Revenue, Cost, Gross Margin)
Table AbbVie Overview List
Table Biologics and Biosimilars Business Operation of AbbVie (Sales Revenue, Cost, Gross Margin)
Table Sanofi-Aventis Overview List
Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Sales Revenue, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Biologics and Biosimilars Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
Table Pfizer Overview List
Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Biologics and Biosimilars Business Operation of Novo Nordisk (Sales Revenue, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Biologics and Biosimilars Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
Table Novartis Overview List
Table Biologics and Biosimilars Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
Table Merck Overview List
Table Biologics and Biosimilars Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table 3sbio Overview List
Table Biologics and Biosimilars Business Operation of 3sbio (Sales Revenue, Cost, Gross Margin)
Table Changchun High Tech Overview List
Table Biologics and Biosimilars Business Operation of Changchun High Tech (Sales Revenue, Cost, Gross Margin)
Table CP Guojian Overview List
Table Biologics and Biosimilars Business Operation of CP Guojian (Sales Revenue, Cost, Gross Margin)
Table Biotech Overview List
Table Biologics and Biosimilars Business Operation of Biotech (Sales Revenue, Cost, Gross Margin)
Table Gelgen Overview List
Table Biologics and Biosimilars Business Operation of Gelgen (Sales Revenue, Cost, Gross Margin)
Table Innovent Overview List
Table Biologics and Biosimilars Business Op

“Global Biologics and Biosimilars Market Analysis, Trends and Forecast 2018-2023”

Tags : Global Biologics and Biosimilars Market Biologics and Biosimilars Market Trends Biologics and Biosimilars Market Forecast Biologics and Biosimilars Market Analysis
Name : Shekhar Dussal
View author details : Logic Research and Solutions
For more info : https://www.logicresearch.net/report/biologics-and-biosimilars-market-19825

Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on enewstrack.com disclaims liability for any content contained in this release.